Operating income, growth figures, profitability and how our products have behaved.
Thu, 13/05/2021 - 00:00
0 minOperating income, growth figures, profitability and how our products have behaved.
Related
ROVI REACHED 201.9 MILLION EUROS OF REVENUE IN THE FIRST POST-PANDEMIC QUARTER
Operating revenue decreased by 2% to 201.6 million...
3 min
10/05/2023
ROVI COMMENCES CLINICAL DEVELOPMENT OF A NEW THREE-MONTHLY FORMULATION OF LETROZOLE (LETROZOLE LEBE)
The objective of the new...
6 min
25/04/2023
Madrid, 12 April, 2023
The Universidad Pontificia Comillas, in collaboration with Laboratorios Farmacéuticos ROVI, has created...
3 min
12/04/2023
IMG_7355baja(1).jpg